Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10031384 | 0.95 | GAA (0.37) | GAAALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL16978723 | 0.91 | GAA (0.39) | GAAALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL12211694 | 0.85 | KDM4E (0.32) | GAAMAPTKDM4E | |
| SCHEMBL1105190 | 0.84 | GAA (0.37) | GAAALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL11976505 | 0.82 | GAA (0.42) | GAAALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL9976852 | 0.82 | GAA (0.35) | GAAALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL15497412 | 0.82 | GAA (0.35) | GAAALDH1A1TP53CYP3A4TSHR | |
| SCHEMBL10031356 | 0.80 | ILK (0.33) | GAATP53MAPT | |
| SCHEMBL10031358 | 0.80 | CD44 (0.39) | GAAALDH1A1CYP3A4MAPTHCRTR1 | |
| SCHEMBL16978725 | 0.79 | MAPT (0.45) | GAAALDH1A1TP53TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9680112-B2 | Semiconductor composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-13 | — | — | US | disclosed |
| US-9260451-B2 | Method for producing aromatic compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-02-16 | — | — | US | disclosed |
| US-9260451-B2 | Method for producing aromatic compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-02-16 | — | — | US | disclosed |
| US-9203038-B2 | Electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-01 | — | — | US | disclosed |
| US-20150239901-A1 | Method For Producing Aromatic Compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20150239901-A1 | Method For Producing Aromatic Compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20150123041-A1 | SEMICONDUCTOR COMPOSITION | SAMSUNG ELECTRONICS CO LTD (KR) | 2015-05-07 | — | — | US | disclosed |
| US-20150053961-A1 | ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2015-02-26 | — | — | US | disclosed |
| US-8963131-B2 | Electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-02-24 | — | — | US | disclosed |
| US-8945425-B2 | Semiconductor composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-02-03 | — | — | US | disclosed |
| US-8643001-B2 | Semiconductor composition | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2014-02-04 | — | — | US | disclosed |
| US-20120313081-A1 | ELECTRONIC DEVICE | XEROX CORPORATION (US) | 2012-12-13 | — | — | US | disclosed |
| US-20120261648-A1 | SEMICONDUCTOR COMPOSITION | XEROX CORPORATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120161110-A1 | SEMICONDUCTOR COMPOSITION | XEROX CORPORATION (US) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150239901-A1 | Method For Producing Aromatic Compound | TYR, XDH, CYP1A1 | GAA 3981/4885ALDH1A1 806/4885TP53 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.